Modern herbal medicines, often available in pill or capsule formats, may have already demonstrated their safety and efficacy in markets outside the U.S. through widespread daily use on large populations. ABDA and collaborating research institutions work together to identify those potential botanical products for botanical drug INDs in the U.S.
ABDA acknowledges that the development of botanical drugs can be resource-intensive, especially for smaller herbal medicine companies lacking sufficient funding. ABDA establishes "Botanical Drugs Impact Fund" to collectively advance the development of botanical drugs.